Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

View source ↗

Summary

This is a USA post-approval long-term follow-up study of the XIENCE V everolimus-eluting coronary stent system; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis
• Coronary Restenosis
• Myocardial Ischemia
• Total Occlusion of Coronary Arteries

Drugs mentioned

• XIENCE V Everolimus Eluting Coronary Stent System (Everolimus-eluting coronary stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Coronary Occlusion, Vascular Disease | Status: COMPLETED | Results posted: 2013-10-11